Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.

Luigi AurisicchioErika SalvatoriLucia LioneSilvio BandiniMatteo PalloccaRoberta MaggioMaurizio FanciulliFrancesca De NicolaFrauke GoemanGennaro CilibertoAntonella ConfortiLaura LubertoFabio Palombo

Published in: Journal of experimental & clinical cancer research : CR (2019)

These results suggest a feasible strategy for a neoantigen cancer vaccine that is simple and applicable for clinical developments.

Keyphrases

papillary thyroid
squamous cell
lymph node metastasis
squamous cell carcinoma
childhood cancer
cancer therapy